The first experimental coronavirus vaccine was put on trial at the Kaiser Permanente Washington Health Research Institute in Seattle on Monday, in research funded by a National Institute of Health (NIH).
The first volunteer to receive the first dose of vaccine was a 43-year-old healthy volunteer, Jennifer Haller, mother of two from Seattle.
“This is an amazing opportunity for me to do something,” Jennifer Haller told Associated Press news agency.
The vaccine was created by Moderna Inc, a biotechnology company by using pre-existing technologies and its called mRNA-1273. It does not contain any part of Covid-19 but contains a harmless generic code called mRNA which has been copied from the virus and was produced in the laboratory.
Different volunteers will be given different doses of the experimental vaccine. The volunteers will be given two jabs of the vaccine in total over 28 days apart into their upper arm muscle.
Scientists plan to enrol 45 healthy volunteers between the ages of 18-45 in the trial during the next six weeks to assess if the vaccine is safe and works against the novel coronavirus with effectiveness.
Four volunteers were vaccinated on Monday and the dose of vaccine is to be given to four more on Tuesday.
While the vaccine design and manufacture were produced extremely rapidly, it has been said that it would take a substantial period of time to test the vaccine. But if the vaccine trial succeeds it would take about a year to make it available to the public.